Cardio Oncology

Florida Society of Clinical Oncology Cardio-Oncology Initiative

In collaboration with the Florida Chapter of the American College of Cardio oncology, FLASCO has worked to identify knowledge gaps in cardio-oncology. This successful collaboration began with a survey  and  has resulted in the development of a series of information cards used to increase the awareness of cardio-oncology issues.

Thank you to the FLASCO members that participated in the cardio-oncology survey. Key highlights include:

• 50%  said there are no Cardio Oncology Services in their community, 42% said yes, 8% didn’t even know.
• From those who said yes (they have CO services in their community), 66% have not referred any patients to them.
• 90% said CO services are of value to their communities

These Cardio-Oncology Information Cards are timely educational materials with reviews of important clinical subjects, brief outlines of what to be aware of, and a few selected references that can be reviewed quickly to help increase awareness of cardio-oncology issues. Download and Share them today.

• 5-FU and Capecitabine
  Diego Sadler, MD, FACC
• Anthracycline Cardio-Toxicity: The Calm Before the Storm
  Anita M. Arnold, DO, FACC, MBA
• Arrhythmias and QT Prolongationin Cancer Patients
  Michael Fradley, MD, FACC
• Cardiac Imaging for Early Detection of Cancer Therapeutics-Related Cardiac Dysfunction
  Patricia Guerrero, MD, FACC
• Immune Check Point Inhibitors
  Diego Sadler, MD, FACC
• Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: ASCO
  Clinical Practice Guidelines. Taken from: Journal of Clinical Oncology 2017 35:8, 893-911
  Compiled by Deepti Bhandare, MD, FACC
• Proteasome Inhibitors
  Patricia Guerrero, MD, FACC
• Radiation toxicity
  Michael Fradley, MD
• Trastuzumab
  Roohi Ismail-Khan, MD
• Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer
  Karla Quevedo, MD, FACC